it is likely that
differences in pressures generated by the two different
methods of compression during the initial treatment phase
of the DLT protocol may have accounted for the observed
differences in both volume reduction and DASH scores. We
observed worsening edema and/or DASH scores during
therapy in a small number of cases. This may be explained
by the fact that our patient population was accrued from
active oncology practices and most of those accrued,
although >3 months post-surgery/radiation as specified in
the eligibility criteria, were still relatively early in follow-up
and were mostly referred due to new-onset lymphedema
which may have been in evolution during the treatment
phase.